| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c5e77c181522ee1fd44df1ae5ac2196 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 |
| filingDate |
2018-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bd473c82f1bc9f50f2abe5f9221bb5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf63bc2558f8a4e1cc79ceccebe80160 |
| publicationDate |
2020-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200046022-A |
| titleOfInvention |
Treatment of CNS conditions |
| abstract |
Aspects of the invention are compositions comprising an effective amount of (4-benzyl-4-hydroxypiperidin-1-yl) (2,4'-bipyridin-3-yl) methanone or a pharmaceutically acceptable salt thereof It relates to a method of treating epilepsy encephalopathy in a mammal in need of treatment of epilepsy encephalopathy, comprising the step of administering to a mammal. |
| priorityDate |
2017-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |